Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Depression 3Breast Neoplasms 3Neoplasms 2Hot Flashes 2Pain 1Mental Disorders 1Lymphoma, Follicular 1Depressive Disorder, Major 1Caregiver Burden 1Anxiety Disorders 1

Interventions

Music Therapy 15Therapeutics 14Surveys and Questionnaires 13Cognitive Behavioral Therapy 13Psychiatric Rehabilitation 12Methods 9Standard of Care 8Educational Status 8Early Intervention, Educational 8Psilocybin 7Mindfulness 6Ketamine 6Hypnosis 6Control Groups 6Aromatherapy 6Acupuncture Therapy 6Mindfulness-Based Stress Reduction 5Mindfulness-Based Cognitive Therapy 5Massage 5Counseling 5Art Therapy 5Saline Solution 4Interviews as Topic 4Imagery, Psychotherapy 4Esketamine 4Caregivers 4Behavior Therapy 4Autogenic Training 4Yoga 3Weights and Measures 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anxiety Disorders × Citalopram × Clear all
NCT00774813 2008-10-17

Nexalin Therapy for the Treatment of Depressive Symptoms

Kalaco Scientific, Inc.

Phase 2 Completed
120 enrolled
Lymphoid

Anxiety Disorders, Depression, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡